Intensive Behavioral Program Arm for Childhood Obesity
This trial found that pharmacotherapy helped facilitate weight loss in adolescents with severe obesity when used in conjunction with low-intensity behavioral counseling.
- Childhood Obesity
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is Intensive Behavioral Program Arm likely to cause serious harm to people?
"While there is some evidence of safety, the lack of efficacy data drops Intensive Behavioral Program Arm's score to a 2."
Are there any vacancies in this research project for willing test subjects?
"Yes, this trial is still ongoing and looking for participants. It was originally posted on March 15th, 2022 and updated two days ago on the 17th."
Has this clinical trial been done before?
"Intensive Behavioral Program Arm has been the subject of clinical research trials since 2018. The first study was sponsored by Novo Nordisk A/S and took place in that same year. It involved 1387 patients. After this initial Phase 4 drug approval trial in 2018, there have been 58 active Intensive Behavioral Program Arm trials spread out over 766 cities and 55 countries."
If a person is under the age of 65, can they participate in this research project?
"The age range that is eligible for this clinical trial according to the inclusion criteria is 12 to 17 years old."
What population does Intensive Behavioral Program Arm typically target?
"The Intensive Behavioral Program Arm is often used in the treatment of chronic weight management. Additionally, this course of action can be taken to help patients with comorbid conditions that are related to weight, including a reduced-calorie diet and exercise."
Are there other medical studies that compare the Intensive Behavioral Program Arm to other treatments?
"Currently, there are 58 ongoing trials related to the Intensive Behavioral Program Arm. Most of these studies are in Phase 3 and 27 of them are based in Loma Linda, California. However, clinical trials for this topic are being conducted at 3894 different locations worldwide."
Which types of patients does this study seek to enroll?
"Candidates between the ages of 12 and 17 who suffer from pediatric obesity have a chance to be a part of this clinical trial. Out of the 120 candidates that will be accepted, researchers are looking for those who fit these specific inclusion criteria."
How many willing test subjects are needed for this experiment?
"Yes, the information on clinicaltrials.gov says that this trial is actively seeking patients. The study was originally posted on 3/15/2022 and was most recently edited on 3/17/2022. The trial is recruiting for 120 patients across 1 sites."